[{"id":"2d6f067a-425c-449b-8c67-22698e557dfa","acronym":"","url":"https://clinicaltrials.gov/study/NCT05941936","created_at":"2023-07-12T16:10:19.072Z","updated_at":"2024-07-02T16:35:43.405Z","phase":"Phase 1","brief_title":"A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors","source_id_and_acronym":"NCT05941936","lead_sponsor":"Suzhou BlueHorse Therapeutics Co., Ltd.","biomarkers":" CD8 • MUC16 • CD4","pipe":"","alterations":" ","tags":["CD8 • MUC16 • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • LM103"],"overall_status":"Recruiting","enrollment":" Enrollment 5","initiation":"Initiation: 05/19/2023","start_date":" 05/19/2023","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 02/01/2026","study_completion_date":" 02/01/2026","last_update_posted":"2023-07-12"}]